Natural Peptide Counters Multiple Hallmarks of Alzheimer’s

 Can your doctor rub a couple of neurons together and get human testing going? Or is sitting with heads up the ass the likely outcome?

Natural Peptide Counters Multiple Hallmarks of Alzheimer’s

Summary:

Researchers at UC San Diego have identified catestatin (CST), a naturally occurring peptide fragment, that simultaneously reduces amyloid and tau buildup, quells neuroinflammation, and improves cognitive and motor performance in mouse models of neurodegenerative disease. Unlike single-target therapies, CST acts across several interconnected pathological pathways, pointing toward a versatile peptide-based treatment strategy for complex dementias.

Key Facts:

• Multi-Target Clearance: In preclinical mouse models, treatment with catestatin significantly reduced toxic accumulations of both tau and amyloid proteins while dialing down neuroinflammation.
• Functional Recovery: Beyond clearing hallmark neuropathology, the peptide led to measurable improvements in both cognitive performance and motor coordination in animal models.
• Derived from Chromogranin A: CST is an endogenous cleavage product of chromogranin A, a protein fundamental to neurotransmitter storage and cellular signaling, and is currently being explored for its ability to reprogram brain energy metabolism to shield vulnerable neurons against cellular stress.

Source: University of California San Diego School of Medicine

Alzheimer’s disease and related dementias present one of the most stubborn hurdles in modern neurology, primarily because their pathology is not driven by a single isolated defect. Instead, disease progression involves an entangled network of problems: aberrant protein aggregation, persistent neuroinflammation, metabolic dysfunction, and progressive synaptic failure.

While many experimental drugs focus narrowly on single targets, such as clearing amyloid plaques or blocking tau tangles, a research team at the University of California San Diego School of Medicine and the VA San Diego Healthcare System took a different approach. In a study published in Molecular Therapy, the scientists investigated whether an endogenous peptide could intervene across multiple disease mechanisms simultaneously.

Their focus fell on catestatin (CST), a naturally occurring peptide fragment derived from chromogranin A. In animal models, CST not only cleared pathological hallmarks but also protected functional neural circuits.

“Neurodegenerative diseases involve multiple interconnected problems — including misfolded proteins, neuroinflammation and progressive dysfunction of brain cells,” said senior author Sushil K. Mahata, PhD, professor of medicine at UC San Diego School of Medicine and research physiologist at the VA San Diego Healthcare System.

“Our findings show that CST can act across several of these disease-associated pathways and shift the brain toward a healthier state. More broadly, the study suggests that peptide-based therapies may offer a new approach to treating complex neurodegenerative diseases.”

Reducing Amyloid, Tau, and Neuroinflammation

To evaluate the peptide’s therapeutic potential, the investigators administered CST to mouse models displaying hallmark features of neurodegenerative decline. The treatment produced widespread structural and cellular benefits:

• Toxin Clearance: CST significantly blunted the accumulation of both amyloid and tau aggregates, the twin proteinopathies characteristic of Alzheimer’s disease.
• Anti-Inflammatory Modulation: The peptide suppressed chronic neuroinflammatory signaling, reducing destructive immune activation in brain tissue.
• Behavioral and Motor Gains: Mice receiving CST demonstrated meaningful improvements in memory, learning tasks, and motor performance compared to untreated controls.

Because chromogranin A is naturally involved in cellular communication and the packaging and release of hormones and neurotransmitters, its derivative CST already plays diverse roles across cardiovascular, metabolic, and immune regulation throughout the body. This native systemic versatility appears to translate to the central nervous system, where it orchestrates several defensive processes rather than engaging only one receptor.

Cellular Resilience and Metabolic Support

Beyond cleaning up cellular debris and cooling inflammatory fires, the researchers are examining how CST alters neuronal bioenergetics.

“One exciting aspect of our findings is that CST may do more than reduce the pathological features of neurodegeneration. We are also investigating whether CST can alter how the brain produces and uses energy, which may help neurons become more resilient to the cellular stress that occurs during neurodegeneration,” said lead author Suborno Jati, PhD, a postdoctoral scholar at UC San Diego School of Medicine.

By potentially stabilizing how distressed brain cells generate and utilize ATP, CST could give damaged neurons the energetic bandwidth required to maintain synaptic communication despite accumulating toxic stressors.

The Path Forward

The researchers emphasize that the current findings are strictly preclinical. Moving CST or related peptide analogues from laboratory animal models into human clinical trials will require comprehensive studies to determine long-term safety, optimal dosing regimens, blood-brain barrier delivery dynamics, and clinical efficacy.

Nevertheless, the discovery highlights the promise of peptide therapeutics as multi-system regulators capable of treating the multifaceted biology of neurodegenerative decline.

Funding: The research was supported in part by grants from the National Institutes of Health and the U.S. Department of Veterans Affairs.

Mahata is founder of CgA Therapeuticals, Inc. and co-founder of Siraj Therapeutics. Mahata and Jati are listed as co-inventors on intellectual property related to the findings.

Editorial Notes:

• This article was edited by a Neuroscience News editor.
• Journal paper reviewed in full.
• Additional context added by our staff.

About this Genetics and Neuroregeneration Research:

• Media Contact: Miles Martin
• Source: UCSD
• Image Credit: Image credited to Neuroscience News
• Original Research is Open Access: Molecular Therapy (September 21, 2026). “Catestatin peptide ameliorates tauopathy and amyloidogenesis via adrenergic inhibition.” Authors: Suborno Jati, Satadeepa Kal, Daniel Munoz-Mayorga, Kechun Tang, Debashis Sahoo, Xu Chen, and Sushil K. Mahata.
• DOI: 10.1016/j.ymthe.2026.09.022

Scientists find a way to reverse brain aging

 Ask your competent? doctor to find out what this molecular switch is so you can research it since YOUR DOCTOR WILL DO NOTHING!

Demand your doctor give you a protocol on NAD.

Scientists find a way to reverse brain aging

For decades, brain aging sounded like a one-way street: neurons slow down, memory slips, and the best anyone could hope for was to delay the decline. A wave of new research is challenging that assumption, suggesting that at least some aspects of cognitive aging can be pushed into reverse, not just gently slowed. Instead of a single miracle cure, scientists are uncovering a toolkit of biological switches, lifestyle levers, and targeted therapies that together hint at a future in which an older brain can regain some of its youthful flexibility.

I see a pattern emerging across these studies: the aging brain is far more plastic, and far more responsive to intervention, than the old narrative allowed. From molecular “master switches” that reset cellular programs, to behavioral strategies like intensive language learning and structured memory training, the evidence points toward a new, more hopeful definition of what it means to grow older with a sharp mind.

The new science of a “reversible” aging brain

The most provocative idea in this field is that brain aging is not a single, irreversible process but a collection of changes that can be dialed up or down. Some teams are focusing on the cellular machinery that controls how neurons repair themselves, clear waste, and maintain synapses. When those systems falter, cognition suffers; when they are restored, at least in early experiments, older brains begin to behave more like younger ones. That shift in framing, from inevitable decline to potentially adjustable biology, is what makes recent findings feel so consequential.

 Related video: Study identifies protein that could help protect memory as we age (WKYC-TV Cleveland)

One widely shared example comes from researchers who describe finding a molecular “master switch” that appears to govern key aspects of brain aging. In social media posts summarizing their work, they report that when this switch was experimentally flipped in older brain cells, markers of aging reversed and youthful patterns of activity re-emerged, a claim that has fueled intense interest in a possible master switch of brain aging. While the details are still being scrutinized and the work remains far from clinical use, the concept aligns with a broader body of peer‑reviewed research showing that age-related changes in gene expression and synaptic function are not fixed, but can be modulated under the right conditions.

How learning reshapes the aging brain

One of the clearest demonstrations that older brains can be remodeled comes from studies of intensive learning. When older adults take on demanding new skills, such as mastering a foreign language, their brains respond with structural and functional changes that look strikingly youthful. Imaging work has shown that language learners in later life can increase gray matter density and strengthen white matter tracts in regions tied to memory and attention, suggesting that the act of sustained learning itself can roll back some of the neural signatures of aging.

In reports on cognitive training, researchers describe how older volunteers who committed to rigorous language courses showed measurable gains in processing speed and working memory, along with brain scans that resembled those of much younger participants, an effect highlighted in coverage of learning a new language and brain aging. The implication is not that vocabulary drills are a magic pill, but that the brain’s plasticity can be reawakened when it is pushed beyond routine habits. I read these findings as a strong argument for treating challenging education in later life less as a hobby and more as a serious, evidence-backed intervention.

Memory, synapses, and the mechanics of cognitive repair

Behind the scenes of any cognitive comeback is a microscopic drama at the level of synapses, the junctions where neurons communicate. Age tends to erode the strength and number of these connections, which is why memory often feels less reliable over time. Experimental work in animals and humans has shown that when synaptic plasticity is restored, memory performance can rebound, sometimes dramatically. That is where a growing set of molecular and behavioral interventions is converging: on the machinery that stabilizes new memories and preserves old ones.

Researchers studying the biology of memory formation have zeroed in on how specific signaling pathways and structural proteins support long‑term storage, and how those systems falter with age. Detailed reviews of synaptic mechanisms describe how long‑term potentiation, dendritic spine density, and activity‑regulated genes can be manipulated to enhance recall, with one open‑access paper on synaptic plasticity and memory laying out the case that these processes remain surprisingly malleable in older brains. In parallel, work at Virginia Tech has highlighted how targeted interventions can improve memory performance in older animals by strengthening specific circuits, with one team reporting that carefully timed stimulation of learning-related pathways led to more durable recall in experiments on improving memory in aging models. Taken together, these lines of evidence suggest that memory decline is not a simple fade-out but a problem of maintenance that can, at least in part, be repaired.

Evidence that cognitive decline can be pushed into reverse

For people already experiencing age-related forgetfulness, the key question is whether any of this science translates into real-world gains. Some of the most encouraging data come from structured programs that combine lifestyle changes, cognitive training, and close monitoring of health markers. In these settings, older adults who were already noticing slips in memory have, in some cases, shown not just stabilization but measurable improvement in cognitive scores, hinting that decline can be nudged back toward baseline when multiple levers are pulled at once.

One report aimed at older readers describes how participants over 65 engaged in a mix of brain exercises, physical activity, and diet adjustments, and then saw objective gains in attention and recall that researchers interpreted as a partial reversal of age-related decline, a finding summarized in coverage of how scientists discovered you can reverse brain aging after 65. In a separate line of work, scientists have used advanced imaging and blood biomarkers to track how interventions affect the brain’s biological age, reporting that certain regimens can shift those measures in a younger direction, as described in a recent release on reversing brain aging signatures. I read these converging results as cautious but real evidence that, under the right conditions, the trajectory of decline is not fixed.

Cellular rejuvenation and the role of NAD

While behavioral strategies work from the outside in, another front in the effort to rejuvenate the brain starts at the level of cellular metabolism. A central player in that story is nicotinamide adenine dinucleotide, or NAD, a molecule that helps power energy production and DNA repair. Levels of NAD tend to fall with age, and that drop has been linked to impaired mitochondrial function and increased vulnerability to neurodegeneration. Restoring NAD has therefore become a major focus for researchers who want to reset the aging clock inside neurons themselves.

Scientists at Stanford and elsewhere have reported that boosting NAD in aging brain cells can improve their ability to clear damaged proteins, maintain synapses, and resist stress, findings that have been translated into practical guidance on how to take care of aging brain cells. In these accounts, interventions that support NAD levels, including specific precursors and lifestyle strategies, are framed not as cosmetic tweaks but as ways to restore fundamental housekeeping functions that keep neurons youthful. While clinical trials are still sorting out which approaches are safe and effective at scale, the mechanistic logic is compelling: if you can restore the cell’s energy and repair systems, you give the brain a better shot at rebuilding itself.

What brain training and public health messaging get right

Alongside lab-based work, a parallel ecosystem of brain training programs and public health campaigns has tried to translate the science into everyday habits. Some of these efforts are more evidence-based than others, but the best of them share a few core principles: they emphasize sustained, progressively challenging mental activity; they pair cognitive work with physical exercise and sleep hygiene; and they treat social connection as a non‑negotiable ingredient in brain health. When those elements come together, the result is less a quick fix and more a long-term training plan for neural resilience.

Public-facing videos and explainers have helped popularize this message, walking viewers through how targeted exercises can strengthen attention, working memory, and processing speed in older adults. One widely viewed segment on brain training for seniors illustrates how structured tasks can be scaled to different ability levels, while another video on neuroplasticity and aging breaks down the science of how repeated practice reshapes circuits. I see these efforts as imperfect but useful bridges between complex lab findings and the daily routines that actually determine whether an older brain is being challenged enough to change.

Limits, risks, and what still counts as unverified

For all the excitement around rejuvenation, it is important to be clear about what the evidence does not yet show. Most of the most dramatic reversals have been observed in animal models or in small, carefully selected groups of human volunteers. Many interventions that look promising in mice fail to deliver in large, diverse clinical trials. Some claims circulating online about instant cures or guaranteed reversal of dementia are not supported by the peer‑reviewed literature and remain unverified based on available sources. The brain is not a simple machine that can be reset with a single pill or switch.

Responsible coverage has started to reflect this nuance, highlighting both the potential and the caveats. One recent news feature on aging and brain health underscores that while lifestyle and emerging therapies can meaningfully shift risk and performance, they do not erase the influence of genetics, early life experiences, or broader social determinants of health. I find that tension instructive: the science is opening doors to genuine rejuvenation in specific domains, but it is not rewriting every rule of biology. For now, the most realistic path to a younger-feeling brain combines ambitious but grounded expectations with a willingness to engage in the slow, daily work of learning, moving, and caring for the cells that carry our memories.

More from MorningOverview

• Did archeologists find 10-foot giants in Nevada cave?
• Astronomers track object entering solar system at impossible speed
• Toyotas water powered engine could signal the fall of EV’s
• Giant underground structures uncovered on mars by NASA

Factors involved in human healthy aging: insights from longevity individuals

 I'm not worried about these specifics, I just know I'm going to get there.

Factors involved in human healthy aging: insights from longevity individuals 

Higher Education Press

image: 

A comprehensive overview of the multifactorial determinants of human longevity.

view more 

Credit: Fan-Qian Yin, Fu-Hui Xiao, Qing-Peng Kong

Human healthy aging and longevity are complex phenomena influenced by a dynamic interplay of genetic, epigenetic, metabolic, immune, and environmental factors. Long-lived individuals (LLIs), particularly centenarians, serve as valuable models for understanding these mechanisms due to their ability to delay or avoid age-related diseases. This overview synthesizes current insights into the multifaceted determinants of exceptional longevity, highlighting key findings from studies on LLIs across diverse populations.

LLIs, defined as individuals surviving beyond 90 years, exhibit distinct characteristics such as reduced morbidity, delayed onset of chronic diseases, and preserved physiological functions. They often cluster in “longevity blue zones” like Okinawa and Sardinia, where lifestyle and environmental factors interact with genetic predispositions. Gender differences are evident, with females comprising most centenarians, though male centenarians tend to have fewer age-related diseases. LLIs can be categorized into “escapers,” “delayers,” and “survivors” based on disease history, reflecting heterogeneous pathways to longevity.

Genetic factors contribute significantly to longevity, with familial clustering indicating a heritable component. Key nuclear genomic variants include APOE ε2 (protective against cardiovascular disease and Alzheimer’s), FOXO3A (linked to oxidative stress resistance and DNA repair), and SIRT6 (involved in genome maintenance). Mitochondrial haplogroups like J and D are associated with reduced oxidative stress, while telomere maintenance genes (hTERT, TERC) ensure chromosome stability. However, genome-wide association studies (GWAS) highlight APOE and FOXO3A as the most consistently linked genes across populations, underscoring their pivotal roles.

Epigenetic mechanisms bridge genetics and environment. DNA methylation patterns in LLIs show delayed age-related methylation loss, particularly in heterochromatin regions, which may stabilize genome integrity. Noncoding RNAs, such as miR-363* and lncRNAs THBS1-IT1/AS1, regulate cellular senescence and gene expression, contributing to healthy aging. These epigenetic signatures correlate with younger biological age and reduced disease risk in LLIs and their offspring.

Metabolic profiles in LLIs are characterized by favorable lipid metabolism (low LDL cholesterol, high HDL), reduced insulin resistance, and enhanced antioxidant capacity. Endocrine factors like low thyroid hormone levels and preserved sex hormones (estradiol in females, testosterone in males) play protective roles. Caloric restriction (CR), a well-established longevity intervention in model organisms, mimics metabolic states in LLIs, improving glucose tolerance and reducing inflammation. CR mimetics, such as metformin and resveratrol, show promise in translating these benefits to humans without dietary restriction.

Immune system alterations in LLIs include reduced chronic inflammation (“inflammaging”) and preserved immune cell function. Centenarians exhibit lower IL-6 levels, higher TGF-β and IL-10 (anti-inflammatory cytokines), and maintained T-cell proliferation and natural killer cell activity. The balance between pro-inflammatory Th17 cells and regulatory T cells (Tregs) shifts toward anti-inflammatory states, contributing to disease resistance.

Environmental and lifestyle factors are equally critical. Gut microbiota in LLIs features increased diversity and enrichment of health-promoting taxa like Akkermansia muciniphila and Bifidobacterium, which enhance gut barrier function and produce anti-aging metabolites. Plant-based diets rich in vegetables, whole grains, and nuts correlate with lower risk of diabetes, cardiovascular disease, and neurodegeneration. Regular physical activity, particularly endurance and strength training, improves metabolic health and extends lifespan through mechanisms like mitochondrial biogenesis and reduced oxidative stress. Other key lifestyle factors include non-smoking, moderate alcohol intake, adequate sleep, and stress management, which collectively reduce mortality risk.

Socioeconomic and medical advancements, such as improved sanitation, vaccination, and healthcare, have significantly increased average life expectancy, though genetic and epigenetic factors determine exceptional longevity. Future research leveraging multi-omics (transcriptomics, proteomics, metabolomics) on large LLI cohorts will deepen understanding of interactive mechanisms. Functional studies in model organisms and clinical trials of longevity-promoting interventions (e.g., probiotics, CR mimetics) are essential to translate findings into therapeutic strategies.

In summary, human longevity emerges from a synergistic interplay of genetic resilience, epigenetic stability, metabolic adaptability, immune balance, and healthy lifestyles. LLIs exemplify how these factors converge to delay aging and disease, offering actionable insights for promoting healthspan. As global aging populations grow, unraveling these mechanisms holds promise for developing personalized interventions to extend both lifespan and quality of life.

---

Journal

Frontiers of Medicine

DOI

10.1007/s11684-024-1120-4 

New study challenges notion that aging means decline, finds many older adults improve over time

 I'm certainly not declining.

New study challenges notion that aging means decline, finds many older adults improve over time

Aging in later life is often portrayed as a steady slide toward physical and cognitive decline. But a new study by scientists at Yale University suggests an alternate narrative — that older individuals can and do improve over time, and their mindset toward aging plays a major part in their success.

Analyzing more than a decade of data from a large, nationally representative study of older Americans, lead author Dr. Becca R. Levy, PhD, a professor of social and behavioral sciences at the Yale School of Public Health (YSPH), found that nearly half of adults aged 65 and older showed measurable improvement in cognitive function, physical function, or both, over time.

The improvements were not limited to a small group of exceptional individuals and, notably, were linked to a powerful but often overlooked factor: how people think about aging itself.

“Many people equate aging with an inevitable and continuous loss of physical and cognitive abilities,” said Dr. Levy, an international expert on psychosocial determinants of aging health. “What we found is that improvement in later life is not rare, it’s common, and it should be included in our understanding of the aging process.”

The findings are published in the journal Geriatrics.

Improvement in later life is not rare; it’s common, and it should be included in our understanding of the aging process.

Becca Levy, PhD

Professor of Public Health (Social and Behavioral Sciences) and Psychology

For the study, the researchers followed more than 11,000 participants in the Health and Retirement Study, a federally supported longitudinal survey of older Americans. The research team tracked changes in cognition using a global performance assessment, and physical function using walking speed — often described by geriatricians as a “vital sign” because of its strong links to disability, hospitalization, and mortality.

Over a follow-up period of up to 12 years, 45% of participants improved in at least one of the two domains, according to the study. About 32% improved cognitively, 28% improved physically, and many experienced gains that exceeded thresholds considered clinically meaningful. When participants whose cognitive scores remained stable over that period (rather than declining) were included, more than half defied the stereotype of inevitable deterioration in cognition.

“What’s striking is that these gains disappear when you only look at averages,” said Dr. Levy, author of the book “Breaking the Age Code: How Your Beliefs About Aging Determine How Long & How Well You Live.”

“If you average everyone together, you see decline," Dr. Levy continued. "But when you look at individual trajectories, you uncover a very different story. A meaningful percentage of the older participants that we studied got better.”

The authors also examined potential reasons for why some people improve and some do not. They hypothesized that an important factor could be participants’ baseline age beliefs — or, specifically, whether they had assimilated more positive or more negative views about aging by the start of the study. In support of this hypothesis, they found that those with more positive age beliefs were significantly more likely to show improvements in both cognition and walking speed, even after accounting for factors such as age, sex, education, chronic disease, depression, and length of follow-up.

The findings build on Dr. Levy’s stereotype embodiment theory, which posits that age stereotypes absorbed from culture — through a range of domains including social media and advertisements — eventually become self-relevant and biologically consequential. Dr. Levy’s prior studies have found negative age beliefs predict poorer memory, slower walking speed, higher cardiovascular risk, and biomarkers associated with Alzheimer’s disease.

The current study shows that those who have assimilated more positive age beliefs often show improvement, Dr. Levy said.

“Our findings suggest there is often a reserve capacity for improvement in later life,” she said. “And because age beliefs are modifiable, this opens the door to interventions at both the individual and societal level.”

The improvements were not limited to people who started out with impairments. Even among participants who had normal cognitive or physical function at baseline, a substantial proportion improved over time. That challenges the assumption that later-life gains reflect only people getting better after being sick or rebounding from earlier setbacks, the authors said.

The authors hope their findings will reverse the popular perception that continuous decline is inevitable and encourage policy makers to increase their support for preventive care, rehabilitation, and other health-promoting programs for older persons that draw on their potential resilience.

Dr. Martin Slade, MPH, PhD, a lecturer in occupational medicine at Yale School of Medicine and in the Department of Environmental Health Sciences at YSPH, is co-author of the study.

This research was supported by funding from the National Institute on Aging.

Surface EMG-based classification and prediction of Fugl-Meyer upper extremity scores in subacute stroke

 Nothing here is of any use to recovery!  Fugl-Meyer has no objectivity at all, so you can't map recovery protocols to your scores!

'Assessments' like Fugl-Meyer NEVER GET ANYONE RECOVERED! I'd have you all fired for incompetency in not solving stroke!

Surface EMG-based classification and prediction of Fugl-Meyer upper extremity scores in subacute stroke

• Hao-Ping Lin,
• Lina Zhao,
• Daniel Woolley,
• Xue Zhang,
• Weidi Liang,
• Hsiao-ju Cheng,
• Lixin Zhang &
• Nicole Wenderoth 

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Background

Stroke is a leading cause of long-term disability worldwide, and with rising incidence and a global shortage of rehabilitation professionals, there is a growing need for scalable methods to assess motor impairment. Surface electromyography (sEMG) has emerged as a promising modality for capturing motor function. Despite its potential, sEMG remains underused in clinical practice and has been predominantly studied in chronic stroke populations, leaving the subacute phase largely unexplored. Its ability to complement standardized assessments is not yet well established.

Methods

Bilateral sEMG was recorded from 23 subacute stroke participants performing four standardized wrist and hand tasks. Task-level features were extracted to train machine learning models to classify the presence of an impairment (affected or less-affected) and the level of impairment, as measured by the Upper Extremity Fugl-Meyer Assessment (FMA-UE) and its wrist and hand subsections (FMA-WH). Models were evaluated using leave-one-subject-out cross-validation (LOSO-CV). Benchmark regression models used therapist-rated subscores as inputs and paired t-tests compared their absolute errors against those of the sEMG-based models. Model interpretability was examined using SHapley Additive exPlanations values (SHAP) to identify sEMG features contributing most strongly to predicted impairment levels.

Results

For impairment classification, Wrist Extension yielded the highest performance in classifying impairment (Accuracy 0.87 ± 0.16; Area Under the Receiver Operating Characteristic [AUC-ROC] 0.96 ± 0.07). An evaluation of all binary and triple task combinations revealed that Wrist Extension combined with Pincer Grasp achieved the best overall classification (Accuracy 0.92 ± 0.12; AUC-ROC 0.99 ± 0.03). For impairment level estimation, the sEMG-based predictions reached a Root Mean Squared Error (RMSE) of 3.12 for FMA-WH and 6.68 for FMA-UE. SHAP analysis with the sEMG-based model revealed that higher extensor activation strongly drove higher predicted scores.

Conclusions

Using sEMG signals obtained from a consumer-grade armband during hand and wrist tasks enabled estimation of partial and full FMA-UE scores, achieving prediction errors below the minimally clinically important difference (MCID) of the full FMA-UE. Furthermore, a two-task protocol (Wrist Extension + Pincer Grasp) achieved the highest classification accuracy, demonstrating that clinical assessment burden could be reduced without compromising performance. This highlights the potential for scalable and portable assessment solutions, though larger longitudinal validation is required.

Oxford and Harvard found the same longevity habits add a decade of healthy life. Here's what they are

 I'm pretty good at all of these.

Oxford and Harvard found the same longevity habits add a decade of healthy life. Here's what they are

Most people assume their lifespan is mostly written in their DNA. Two of the largest studies ever conducted on aging say otherwise, and the numbers they’ve produced are striking enough to change how you think about the next decade.

A 10-year gap in healthy, disease-free living separates people who practice a handful of daily habits from those who don’t. That gap isn’t estimated. It’s been measured across hundreds of thousands of people, and the habits responsible are more accessible than most people expect.

Why Your 50s Are the Highest-Leverage Decade for Longevity

My brain aging dropped off a cliff at age 50 from the stroke. I had just completed a 6 day whitewater canoeing trip in Canada, 23 miles falling 1100 feet, only 5 portages. One of those being 1.5 miles long. On the Dog River, Ontario by Wawa. Life is great now, 20 years later. I'm easily going to get to 100+. 

At 50 I was in fantastic shape, hell I was carrying canoes and gear on 1.5 mile portages. And something on that trip caused the plaque lining my carotid artery to tear, which then clotted and eventually let go after a 12 hour drive home. 

Biological aging doesn’t accelerate evenly across a lifetime. The 50s are when chronic disease risk climbs fastest, when the gap between biological and chronological age starts to widen, and when the habits you keep have the most runway left to compound.

Frank Hu, MD, PhD, of the Harvard T.H. Chan School of Public Health, who has led much of the landmark Harvard longevity research, has consistently framed midlife as the window where behavior change still pays off most.

The Harvard data show that obesity combined with heavy smoking produces the lowest disease-free life expectancy at 50. Changing either of those factors measurably shifts the outcome.

What Two Major Studies Found About Aging and Daily Habits

A February 2025 Oxford University study published in Nature Medicine analyzed 164 lifestyle and environmental factors across nearly 500,000 UK Biobank participants and reached a conclusion that challenges a deeply held assumption: lifestyle and environment shape how we age and when we die prematurely more than our genetics do.

 Related video: Try these 4 simple tests to see how well your body's aging (VideoElephant - Video)

Smoking status and physical activity emerged as the two most powerful modifiable factors. Early-life exposures, including body weight at age 10 and maternal smoking, also showed measurable effects on aging outcomes decades later, which underscores just how long these influences stretch. But midlife habits remained the strongest lever any individual can actually pull.

The Harvard Nurses’ Health Study and Health Professionals Follow-Up Study put precise numbers on that leverage. Women at age 50 who practiced four or five healthy habits lived roughly 34 more years free of diabetes, cardiovascular disease and cancer, compared to 24 disease-free years for women who practiced none. Men saw 31 versus 24. A 10-year difference in healthy life expectancy, driven entirely by daily behavior.

Which Habits Actually Move the Longevity Needle

Across both studies, the list of highest-impact habits is short:

• Not smoking, the single most harmful modifiable exposure in the Oxford analysis, with biological aging effects measurable long after exposure ends
• Regular physical activity, the second most powerful protective factor in the Oxford data
• A healthy weight, especially when paired with not smoking
• Diet quality, consistently linked to lower rates of hypertension, dementia and chronic disease
• Sleep, flagged by the Oxford UK Biobank analysis as a significant and often overlooked contributor to biological aging
• Moderate alcohol, part of Harvard’s original framework though guidance has shifted toward “less is better” in more recent updates

Stacking four or five of these habits matters more than perfecting any single one. Frank Hu’s team has consistently found that the compounding effect of multiple habits is where the 10-year gap comes from.

Why Variety of Exercise Is Its Own Longevity Factor

A January 2026 Harvard study in BMJ Medicine added a finding most people haven’t heard. Analyzing 111,000 participants over 30 years, researchers found that variety of exercise independently predicts mortality risk, even after controlling for total activity volume. Participants with the highest exercise variety had a 19% lower risk of premature death at every level of overall activity.

That means someone walking the same route every day isn’t getting the same protective effect as someone mixing walking, lifting, cycling and recreational sport. Variety isn’t a bonus feature of a good fitness routine. It’s a separate, measurable longevity signal.

The consistent message across all three studies: genetics set the floor, but daily behavior raises the ceiling. And for most people reading this, the decade when that ceiling moves most is already underway. If you’re also building the physical habits that protect your body as you age, research on bone density and daily habits after 50 is a natural next read.

This article was created by content specialists using various tools, including AI.

Researchers detail habits that could prevent cognitive decline

 Guidelines NOT protocols; so ask your competent? doctor for EXACT PROTOCOLS! You do want to blame your doctor for that decline if the protocols are wrong, right?

Researchers detail habits that could prevent cognitive decline

Around 7.2 million Americans are currently estimated to have Alzheimer's disease,and experts such as those at the National Health Institute say that number could grow to 13.8 million by 2060. As researchers say that indicates clinicians will face "major challenges" in coming years, they are urging people to take a closer look into the lifestyle habits that could help prevent cognitive decline.

While deaths from cardiovascular disease have declined since 2000, deaths from Alzheimer's disease have surged by more than 140%," Dr. Charles H. Hennekens, a professor of Medicine and Preventive Medicine at the Florida Atlantic University Schmidt College of Medicine, told Science Daily. "At the same time, it is estimated that up to 45% of dementia risk could be attributed to modifiable lifestyle and environmental factors."

Hennekens is one of the co-authors of a commentary in "The American Journal of Medicine" that details some of these, which include: physical inactivity; unhealthy diets; obesity and alcohol consumption. Also included are medical conditions like dyslipidemias, hypertension, diabetes and depression as well as social isolation and intellectual inactivity.

On the flip side, there are "therapeutic lifestyle" changes that could help decrease cognitive decline in elderly patients that have been proven to help those with cardiovascular disease as well as other illnesses, researchers wrote. 

 Related video: How to avoid dementia: 8 easy habits that doctors say protect your memory (Woman's World)

These changes include physical activity, adhering to diets like the Mediterranean or DASH diet, and not smoking. 

"Therapeutic lifestyle changes, if demonstrated to be beneficial, would have major clinical and public health implications in reducing cognitive decline in the US and worldwide," researchers said in the commentary. "This possibility is of even greater importance given the interrelationships of cognitive decline with increasing age as well as the increasing proportion of U.S. and other populations of the elderly."

Researchers highlighted the results of the Protect Brain Health Through Lifestyle Interventions to Reduce Risk, or POINTER, trial, where 2,111 men and women between 60 and 79 years old who were at high risk for cognitive decline because of risk factors were given either a "high intensity lifestyle intervention" or a self-guided program.

Those in the high intensity lifestyle intervention group had meetings in person, professional guidance and accountability measures, while the ones who were self-guided had educational materials and "general support." Those in the former group, during the POINTER trial, "demonstrated statistically significant and clinically important improvements in global cognition," particularly when it came to planning, attention and problem solving. Another trial, Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER,) had similar results. 

"There are implications for clinical practice, public health, and government policy, as well as further research," researchers wrote. "Clinicians will now be armed with lifestyle-based changes to reduce cognitive decline. In addition, public health practitioners may also add to their programs based on the study designs of POINTER and FINGER to maintain brain health, complementing pharmacologic approaches."

Not only can these findings be beneficial from a health perspective - researchers said they also could lead to cost savings. Early attention to risk factors of dementia could reduce people's medical and caregiving costs, as well as the "expensive costs of the newly developed pharmacologic agents," some of which offer modest benefits but side effects including "loss of appetite, nausea, vomiting, headache, fatigue and restlessness," researchers noted.

"While more research is needed, the current totality of evidence supports a clear path forward: invest in lifestyle-based strategies to protect brain health," Hennekens said to Science Daily. "Doing so will not only benefit individuals at risk but also serve as a powerful tool for reducing national and global health care burdens related to cognitive decline."

The post Researchers detail habits that could prevent cognitive decline appeared first on Straight Arrow News.

Non-invasive stimulation techniques for fall prevention and balance control: an overview of reviews and meta-analyses

 What is your doctors' EXACT FALL PREVENTION PROTOCOL?  

Oh NO; doesn't have one; THAT'S PURE INCOMPETENCE! 

Dumping that on therapists is not allowed, the doctor is responsible for getting you 100% recovered. And s/he  COMPLETELY FAILED AT THAT, RIGHT? 

Non-invasive stimulation techniques for fall prevention and balance control: an overview of reviews and meta-analyses

• Zhihao Ren,
• Clemens Becker,
• Lorenzo Chiari &
• Pierpaolo Palumbo 

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Background

Older adults and individuals with neurological disorders often experience balance impairments, which increase their risk of falling and compromise their functional independence. Numerous studies and systematic reviews have investigated the use of non-invasive stimulation techniques for fall prevention and balance control across various populations and device types.

Objective

To conduct an overview of systematic reviews assessing the efficacy of non-invasive stimulation techniques for fall prevention and balance control improvement in different target populations.

Methods

The review protocol was registered in the PROSPERO database (CRD420251023003). A systematic search was conducted for systematic reviews published up to March 2025. Reviews evaluating the efficacy of non-invasive stimulation techniques (i.e., non-invasive brain stimulation (NIBS), neuromuscular electrical stimulation (NMES), galvanic vestibular stimulation (GVS), and mechanical stimulation) on fall prevention or balance control in older adults or individuals with neurological disorders were included. The AMSTAR 2 tool was used to assess the methodological quality of the included reviews. Overall and subgroup meta-analyses were performed using random-effects models, with the standardized mean difference (SMD) as the effect size measure.

Results

We identified 21 systematic reviews. Three reviews (including one with a meta-analysis) were excluded from qualitative synthesis due to “low/critical low” quality. The remaining 18 reviews were included in the qualitative analysis, encompassing 328 original studies, which involved 11,692 participants. Of these, 13 reviews were included in the quantitative synthesis, of which 12 were pooled in the meta-analysis. The pooled results showed that non-invasive stimulation techniques had a moderate effect on improving balance control (SMD = 0.43, 95% CI, 0.34–0.52; = 8%, p = 0.366). Funnel plot inspection and Egger’s test (p = 0.267) indicated no evidence of publication bias. Subgroup analyses showed no statistically significant differences: by type of balance outcome (static vs. dynamic, p = 0.777), non-invasive stimulation techniques (p = 0.857), or target population (individuals with stroke or Parkinson’s disease, p = 0.750).

(Without even mentioning what the hell non-invasive interventions are; TOTALLY FUCKING USELESS! Don't your mentors and senior researchers have any clue how to do research?)

Conclusions

Non-invasive stimulation techniques may serve as a moderately effective(NOT GOOD ENOUGH!) therapeutic strategy for improving balance control, with potential functional benefits. The quality of evidence was moderate for NIBS but low for NMES and GVS. However, their clinical relevance should be interpreted with caution. The effectiveness in fall prevention remains to be established due to limited available evidence.

New studies reveal diverse factors shaping aging and longevity

 You'll want EXACT PROTOCOLS instead of this generic crapola so ask your competent? doctor for some! 

NO protocols created? PURE INCOMPETENCE!

New studies reveal diverse factors shaping aging and longevity

Study identifies key cause of accelerated aging

A research study has determined a significant factor contributing to rapid aging. The findings highlight a specific cause that may influence the pace at which aging occurs in individuals. This discovery provides a potential target for further investigation into slowing or mitigating accelerated aging.

References

Study Finds a Big Cause of Fast Aging | Knowridge

Epigenetic aging measured through gene expression patterns

Researchers assessed biological aging by analyzing gene expression patterns, which revealed differences between participants' biological and chronological ages. This method provided evidence that anxiety about aging could manifest in cellular-level changes.

References

What factors speed up aging? | Tribune Content Agency
The healthy-ageing hack that has nothing to do with diet, exercise or genetics | News | CORDIS | European Commission | cordis.europa.eu

Physical activity, diet, and social connections may slow biological aging

The study highlights that factors such as regular physical activity, healthy diet, and maintaining social connections can help slow the process of biological aging. These factors may counteract some of the negative effects associated with anxiety about aging.

References

What factors speed up aging? | Tribune Content Agency
The healthy-ageing hack that has nothing to do with diet, exercise or genetics | News | CORDIS | European Commission | cordis.europa.eu

Regular exercise as a contributor to healthier aging

Studies from multiple institutions emphasize that regular physical activity supports healthier aging. Exercise is presented as one of several interventions that can improve health outcomes in older age.

References

Not diet, not exercise: Scientists say this factor drives longevity | Sciencing
'Selection shadow' may explain why longer lives bring more age-related disease | Phys.org
Why living to 100 may depend on far more than diet and exercise | news-medical.net
Longevity: What might actually help slow down aging? | Medical News Today

Adequate sleep linked to improved aging outcomes

Adequate sleep is identified by researchers as a factor that supports healthier aging. It is considered alongside diet, exercise, and preventive care in promoting better health in later life.

References

Not diet, not exercise: Scientists say this factor drives longevity | Sciencing
'Selection shadow' may explain why longer lives bring more age-related disease | Phys.org
Why living to 100 may depend on far more than diet and exercise | news-medical.net
Longevity: What might actually help slow down aging? | Medical News Today

Sleep quality as a potential key factor in longevity

Research suggests that adequate and good-quality sleep may have a stronger influence on lifespan than diet or exercise. This perspective positions sleep as a potentially more critical factor for healthy aging compared to other lifestyle interventions.

References

Sleep could beat diet and exercise for living longer | Morning Overview

Preventive care's role in promoting healthier aging

Preventive healthcare measures are cited as contributing to healthier aging. These measures are grouped with other lifestyle interventions in research findings from leading universities.

References

Not diet, not exercise: Scientists say this factor drives longevity | Sciencing
'Selection shadow' may explain why longer lives bring more age-related disease | Phys.org
Why living to 100 may depend on far more than diet and exercise | news-medical.net
Longevity: What might actually help slow down aging? | Medical News Today

Public health strategies can mitigate accelerated aging risks

Public health measures that support mental well-being, foster strong social connections, and encourage healthy daily routines may help reduce the risks associated with accelerated aging. These strategies target both psychological and lifestyle factors.

References

What factors speed up aging? | Tribune Content Agency
What Causes Accelerated Aging? The Biological Drivers | Haute MD | hauteliving.com

Metformin's potential influence on DNA methylation patterns linked to aging

Biomarker studies suggest that the medication metformin may affect DNA methylation patterns associated with aging. However, the effects of metformin in healthy individuals remain unproven.

References

Not diet, not exercise: Scientists say this factor drives longevity | Sciencing
'Selection shadow' may explain why longer lives bring more age-related disease | Phys.org
Why living to 100 may depend on far more than diet and exercise | news-medical.net
Longevity: What might actually help slow down aging? | Medical News Today

Metformin and semaglutide effects on DNA methylation patterns linked to aging

Biomarker studies suggest that medications such as metformin and semaglutide may influence DNA methylation patterns associated with aging. However, the effects of these drugs in healthy individuals have not been proven.

References

Not diet, not exercise: Scientists say this factor drives longevity | Sciencing
'Selection shadow' may explain why longer lives bring more age-related disease | Phys.org
Why living to 100 may depend on far more than diet and exercise | news-medical.net
Longevity: What might actually help slow down aging? | Medical News Today

Menopause-associated blood protein signature

Researchers have identified a specific blood protein signature that is associated with menopause. This protein profile is linked to changes in the body that occur during the menopausal transition. The discovery provides a measurable biological marker connected to this life stage in women.

References

Menopause leaves a blood protein signature linked to brain aging and Alzheimer’s risk | News Medical

Identification of Meaningful Biological Shifts in Aging

Researchers are working to identify biological changes that are significant in the context of aging. These shifts could serve as targets for interventions or as indicators of progress in slowing age-related decline. The focus is on distinguishing changes that have a meaningful impact on health and longevity from those that do not.

References

Longevity: What might actually help slow down aging? | Medical News Today

Validation of Biomarker Changes in Aging Research

Future aging research aims to determine whether observed changes in biomarkers actually result in longer and healthier human lifespans. This involves linking measurable biological indicators to tangible improvements in longevity and health outcomes. Establishing this connection is a key step in assessing the effectiveness of potential anti-aging interventions.

References

Longevity: What might actually help slow down aging? | Medical News Today
Study Finds a Big Cause of Fast Aging | Knowridge

Genetic Contributions to Different Frailty Types

Studies may focus on the role of genetics in contributing to various forms of frailty. This research could help identify genetic markers associated with specific frailty patterns and inform targeted prevention or treatment strategies.

References

Longevity: What might actually help slow down aging? | Medical News Today
Study Finds a Big Cause of Fast Aging | Knowridge

Investigation of Promising Pharmacological and Molecular Targets

Ongoing research is exploring pharmacological and molecular targets that show promise in slowing aging. These targets are being studied for their potential to influence biological processes associated with age-related decline.

References

Longevity: What might actually help slow down aging? | Medical News Today

Recommendation of Established Healthy Lifestyle Habits

Experts recommend focusing on established healthy habits such as maintaining a balanced diet, engaging in regular exercise, ensuring quality sleep, and fostering social connections. These practices are supported by evidence for promoting health and longevity.

References

Longevity: What might actually help slow down aging? | Medical News Today
Study Finds a Big Cause of Fast Aging | Knowridge